Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
[No title available]

L' Orthodontie francaise

Béry A, Bounoure G.
PMID: 29043968
Orthod Fr. 2017 Sep;88(3):211. doi: 10.1051/orthodfr/2017021. Epub 2017 Oct 18.

No abstract available.

Cite
Béry A, Bounoure G. Hommage à Julien Philippe . Orthod Fr. 2017;88(3):211doi: 10.1051/orthodfr/2017021.
Béry, A., & Bounoure, G. (2017). Hommage à Julien Philippe . L' Orthodontie francaise, 88(3), 211. https://doi.org/10.1051/orthodfr/2017021
Béry, Alain, and Bounoure, Guy. "Hommage à Julien Philippe" . L' Orthodontie francaise vol. 88,3 (2017): 211. doi: https://doi.org/10.1051/orthodfr/2017021
Béry A, Bounoure G. Hommage à Julien Philippe . Orthod Fr. 2017 Sep;88(3):211. doi: 10.1051/orthodfr/2017021. Epub 2017 Oct 18. French. PMID: 29043968.
Copy Download .nbib Format: NLM
Pharmacokinetic study of metopimazine by oral route in children.

Pharmacology research & perspectives

Mallet E, Bounoure F, Skiba M, Saussereau E, Goullé JP, Castanet M.
PMID: 26171218
Pharmacol Res Perspect. 2015 Jun;3(3):e00130. doi: 10.1002/prp2.130. Epub 2015 Jun 01.

Metopimazine (MPZ) is an antiemetic considered as a currently used drug. In France, it has become the leading antiemetic mediator due to its good tolerance, however, its pharmacokinetics has never previously been studied in children. MPZ was administered by...

Cite
Mallet E, Bounoure F, Skiba M, et al. Pharmacokinetic study of metopimazine by oral route in children. Pharmacol Res Perspect. 2015;3(3):e00130doi: 10.1002/prp2.130.
Mallet, E., Bounoure, F., Skiba, M., Saussereau, E., Goullé, J. P., & Castanet, M. (2015). Pharmacokinetic study of metopimazine by oral route in children. Pharmacology research & perspectives, 3(3), e00130. https://doi.org/10.1002/prp2.130
Mallet, Eric, et al. "Pharmacokinetic study of metopimazine by oral route in children." Pharmacology research & perspectives vol. 3,3 (2015): e00130. doi: https://doi.org/10.1002/prp2.130
Mallet E, Bounoure F, Skiba M, Saussereau E, Goullé JP, Castanet M. Pharmacokinetic study of metopimazine by oral route in children. Pharmacol Res Perspect. 2015 Jun;3(3):e00130. doi: 10.1002/prp2.130. Epub 2015 Jun 01. PMID: 26171218; PMCID: PMC4492748.
Copy Download .nbib Format: NLM
Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer's Disease Treatment.

Pharmaceutics

Adnet T, Groo AC, Picard C, Davis A, Corvaisier S, Since M, Bounoure F, Rochais C, Pluart LL, Dallemagne P, Malzert-Fréon A.
PMID: 32168767
Pharmaceutics. 2020 Mar 11;12(3). doi: 10.3390/pharmaceutics12030251.

Direct nose-to-brain delivery has been raised as a non-invasive powerful strategy to deliver drugs to the brain bypassing the blood-brain barrier (BBB). This study aimed at preparing and characterizing an innovative composite formulation, associating the liposome and hydrogel approaches,...

Cite
Adnet T, Groo AC, Picard C, et al. Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer's Disease Treatment. Pharmaceutics. 2020;12(3)doi: 10.3390/pharmaceutics12030251.
Adnet, T., Groo, A. C., Picard, C., Davis, A., Corvaisier, S., Since, M., Bounoure, F., Rochais, C., Pluart, L. L., Dallemagne, P., & Malzert-Fréon, A. (2020). Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer's Disease Treatment. Pharmaceutics, 12(3), . https://doi.org/10.3390/pharmaceutics12030251
Adnet, Thomas, et al. "Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer's Disease Treatment." Pharmaceutics vol. 12,3 (2020). doi: https://doi.org/10.3390/pharmaceutics12030251
Adnet T, Groo AC, Picard C, Davis A, Corvaisier S, Since M, Bounoure F, Rochais C, Pluart LL, Dallemagne P, Malzert-Fréon A. Pharmacotechnical Development of a Nasal Drug Delivery Composite Nanosystem Intended for Alzheimer's Disease Treatment. Pharmaceutics. 2020 Mar 11;12(3). doi: 10.3390/pharmaceutics12030251. PMID: 32168767; PMCID: PMC7151011.
Copy Download .nbib Format: NLM
Preparation and characterization of amorphous solid dispersions of nimesulide in cyclodextrin copolymers.

Journal of nanoscience and nanotechnology

Skiba M, Skiba M, Milon N, Bounoure F, Fessi H.
PMID: 24734689
J Nanosci Nanotechnol. 2014 Apr;14(4):2772-9. doi: 10.1166/jnn.2014.8587.

A study to enhance the dissolution rate of nimesulide (NIM), a poorly water-soluble, non-steroidal anti-inflammatory drug, was carried out through developing new amorphous solid dispersions (ASD) based on soluble or insoluble water cyclodextrin copolymers (alpha-cyclodextrin, beta-cyclodextrin and y-cyclodextrin polymers)...

Cite
Skiba M, Skiba M, Milon N, et al. Preparation and characterization of amorphous solid dispersions of nimesulide in cyclodextrin copolymers. J Nanosci Nanotechnol. 2014;14(4):2772-9doi: 10.1166/jnn.2014.8587.
Skiba, M., Skiba, M., Milon, N., Bounoure, F., & Fessi, H. (2014). Preparation and characterization of amorphous solid dispersions of nimesulide in cyclodextrin copolymers. Journal of nanoscience and nanotechnology, 14(4), 2772-9. https://doi.org/10.1166/jnn.2014.8587
Skiba, M, et al. "Preparation and characterization of amorphous solid dispersions of nimesulide in cyclodextrin copolymers." Journal of nanoscience and nanotechnology vol. 14,4 (2014): 2772-9. doi: https://doi.org/10.1166/jnn.2014.8587
Skiba M, Skiba M, Milon N, Bounoure F, Fessi H. Preparation and characterization of amorphous solid dispersions of nimesulide in cyclodextrin copolymers. J Nanosci Nanotechnol. 2014 Apr;14(4):2772-9. doi: 10.1166/jnn.2014.8587. PMID: 24734689.
Copy Download .nbib Format: NLM
Enhanced Dissolution and Oral Bioavailability of Cyclosporine A: Microspheres Based on αβ-Cyclodextrins Polymers.

Pharmaceutics

Lahiani-Skiba M, Hallouard F, Bounoure F, Milon N, Karrout Y, Skiba M.
PMID: 30567289
Pharmaceutics. 2018 Dec 18;10(4). doi: 10.3390/pharmaceutics10040285.

Cyclosporine (CsA) has a selective property of suppressing various T-lymphocyte functions. This is of utmost importance in preventing allograft rejection by several organ transplantations, as well as in the treatment of systemic and local autoimmune disorders. However, the poor...

Cite
Lahiani-Skiba M, Hallouard F, Bounoure F, et al. Enhanced Dissolution and Oral Bioavailability of Cyclosporine A: Microspheres Based on αβ-Cyclodextrins Polymers. Pharmaceutics. 2018;10(4)doi: 10.3390/pharmaceutics10040285.
Lahiani-Skiba, M., Hallouard, F., Bounoure, F., Milon, N., Karrout, Y., & Skiba, M. (2018). Enhanced Dissolution and Oral Bioavailability of Cyclosporine A: Microspheres Based on αβ-Cyclodextrins Polymers. Pharmaceutics, 10(4), . https://doi.org/10.3390/pharmaceutics10040285
Lahiani-Skiba, Malika, et al. "Enhanced Dissolution and Oral Bioavailability of Cyclosporine A: Microspheres Based on αβ-Cyclodextrins Polymers." Pharmaceutics vol. 10,4 (2018). doi: https://doi.org/10.3390/pharmaceutics10040285
Lahiani-Skiba M, Hallouard F, Bounoure F, Milon N, Karrout Y, Skiba M. Enhanced Dissolution and Oral Bioavailability of Cyclosporine A: Microspheres Based on αβ-Cyclodextrins Polymers. Pharmaceutics. 2018 Dec 18;10(4). doi: 10.3390/pharmaceutics10040285. PMID: 30567289; PMCID: PMC6321236.
Copy Download .nbib Format: NLM
The effect of camelina oil on vascular function in essential hypertensive patients with metabolic syndrome: A randomized, placebo-controlled, double-blind study.

The American journal of clinical nutrition

Jeremy B, Bozec E, Bounoure F, Khettab H, Malloizel-Delaunay J, Skiba M, Iacob M, Donnadieu N, Coquard A, Morio B, Laillet B, Rigaudière JP, Chardigny JM, Monteil C, Vendeville C, Mercier A, Cailleux AF, Blanchard A, Amar J, Fezeu LK, Pannier B, Bura-Rivière A, Boutouyrie P, Joannidès R.
PMID: 34791007
Am J Clin Nutr. 2021 Nov 15; doi: 10.1093/ajcn/nqab374. Epub 2021 Nov 15.

BACKGROUND: The effects of a dietary supplementation with the vegetable omega-3 α-linolenic acid (ALA) on cardiovascular homeostasis are unclear. In this context, it would be interesting to assess the effects of camelina oil.OBJECTIVE: This study aimed to assess the...

Cite
Jeremy B, Bozec E, Bounoure F, et al. The effect of camelina oil on vascular function in essential hypertensive patients with metabolic syndrome: A randomized, placebo-controlled, double-blind study. Am J Clin Nutr. 2021;doi: 10.1093/ajcn/nqab374.
Jeremy, B., Bozec, E., Bounoure, F., Khettab, H., Malloizel-Delaunay, J., Skiba, M., Iacob, M., Donnadieu, N., Coquard, A., Morio, B., Laillet, B., Rigaudière, J. P., Chardigny, J. M., Monteil, C., Vendeville, C., Mercier, A., Cailleux, A. F., Blanchard, A., Amar, J., Fezeu, L. K., Pannier, B., Bura-Rivière, A., Boutouyrie, P., & Joannidès, R. (2021). The effect of camelina oil on vascular function in essential hypertensive patients with metabolic syndrome: A randomized, placebo-controlled, double-blind study. The American journal of clinical nutrition, . https://doi.org/10.1093/ajcn/nqab374
Jeremy, Bellien, et al. "The effect of camelina oil on vascular function in essential hypertensive patients with metabolic syndrome: A randomized, placebo-controlled, double-blind study." The American journal of clinical nutrition vol. (2021). doi: https://doi.org/10.1093/ajcn/nqab374
Jeremy B, Bozec E, Bounoure F, Khettab H, Malloizel-Delaunay J, Skiba M, Iacob M, Donnadieu N, Coquard A, Morio B, Laillet B, Rigaudière JP, Chardigny JM, Monteil C, Vendeville C, Mercier A, Cailleux AF, Blanchard A, Amar J, Fezeu LK, Pannier B, Bura-Rivière A, Boutouyrie P, Joannidès R. The effect of camelina oil on vascular function in essential hypertensive patients with metabolic syndrome: A randomized, placebo-controlled, double-blind study. Am J Clin Nutr. 2021 Nov 15; doi: 10.1093/ajcn/nqab374. Epub 2021 Nov 15. PMID: 34791007.
Copy Download .nbib Format: NLM
Showing 1 to 6 of 6 entries